Citations

Showing 10 of 108135 citations.

Reply:
Allen, Alina M. , Talwalkar, Jayant A., Allen, Alina M , McCoy, Rozalina G.

Mayo Clinic

Hepatology | June 1, 2019 | Volume: 70 | Issue: 4 | Pages: 1493-1494

10.1002/hep.30796 | PMID 31152591 Get It

Modeling post‐translational modifications and cancer‐associated mutations that impact the heterochromatin protein 1α‐importin α heterodimers
Zimmermann, Michael T. , Williams, Monique M., Klee, Eric W. , Lomberk, Gwen , Urrutia, Raúl , Lomberk, Gwen L , Zimmermann, Michael T , Urrutia, Raul

Mayo Clinic

Proteins: Structure, Function, and Bioinformatics | June 1, 2019 | Volume: 87 | Issue: 11 | Pages: 904-916

10.1002/prot.25752 | PMID 31152607 Get It

AbstractHeterochromatin protein 1α (HP1α) is a protein that mediates cancer‐associated processes in the cell nucleus. Proteomic experiments, reported here, demonstrate that HP1α complexes with importin α (IMPα), a protein necessary for its nuclear transport. This data is congruent with Simple Linear Motif (SLiM) analyses that identify an IMPα‐binding motif within the linker that joins the two globular domains of this protein. Using molecular modeling and dynamics simulations, we develop a model of the IMPα‐HP1α complex and investigate the impact of phosphorylation and genomic variants on their interaction. We demonstrate that phosphorylation of the HP1α linker likely regulates its association with IMPα, which has implications for HP1α access to the nucleus, where it functions. Cancer‐associated genomic variants do not abolish the interaction of HP1α but instead lead to rearrangements where the variant proteins maintain interaction with IMPα, but with less specificity. Combined, this new mechanistic insight bears biochemical, cell biological, and biomedical relevance.
Senescent Kidney Cells in Hypertensive Patients Release Urinary Extracellular Vesicles
Santelli, Adrián, Eirin, Alfonso , Abumoawad, Abdelrhman , Woollard, John R. , Textor, Stephen C., Puranik, Amrutesh S. , Lerman, Lilach O. , Sun, In O , Abumoawad, Abdelrhman M, Eirin, Alfonso , Puranik, Amrutesh S , Lerman, Amir

Mayo Clinic

Journal of the American Heart Association | June 1, 2019 | Volume: 8 | Issue: 11 | Pages: No page available

10.1161/jaha.119.012584 | PMID 31433703 Get It

Background Hypertension may be associated with renal cellular injury. Cells in distress release extracellular vesicles ( EV s), and their numbers in urine may reflect renal injury. Cellular senescence, an irreversible growth arrest in response to a noxious milieu, is characterized by release of proinflammatory cytokines. We hypothesized that EV s released by senescent nephron cells can be identified in urine of patients with hypertension. Methods and Results We recruited patients with essential hypertension ( EH ) or renovascular hypertension and healthy volunteers (n=14 each). Renal oxygenation was assessed using magnetic resonance imaging and blood samples collected from both renal veins for cytokine‐level measurements. EV s isolated from urine samples were characterized by imaging flow cytometry based on specific markers, including p16 (senescence marker), calyxin (podocytes), urate transporter 1 (proximal tubules), uromodulin (ascending limb of Henle's loop), and prominin‐2 (distal tubules). Overall percentage of urinary p16+ EV s was elevated in EH and renovascular hypertension patients compared with healthy volunteers and correlated inversely with renal function and directly with renal vein cytokine levels. Urinary levels of p16 + /urate transporter 1 + were elevated in all hypertensive subjects compared with healthy volunteers, whereas p16 + /prominin‐2 + levels were elevated only in EH versus healthy volunteers and p16 + /uromodulin + in renovascular hypertension versus EH . Conclusions Levels of p16 + EV s are elevated in urine of hypertensive patients and may reflect increased proximal tubular cellular senescence. In EH , EV s originate also from distal tubules and in renovascular hypertension from Henle's loop. Hence, urinary EV s levels may be useful to identify intrarenal sites of cellular senescence.
Total knee arthroplasty after distal femoral osteotomy long-term survivorship and clinical outcomes
Limberg, Afton K. , Athey, Alexander G., Perry, Kevin I. , Pagnano, Mark W. , Chalmers, Brian P. , Abdel, Matthew P.

Mayo Clinic

The Bone & Joint Journal | June 1, 2019 | Volume: 101-B | Issue: 6 | Pages: 660-666

10.1302/0301-620x.101b6.bjj-2018-1334.r2 | PMID 31154844 Get It

AimsThere is little literature about total knee arthroplasty (TKA) after distal femoral osteotomy (DFO). Consequently, the purpose of this study was to analyze the outcomes of TKA after DFO, with particular emphasis on: survivorship free from aseptic loosening, revision, or any re-operation; complications; radiological results; and clinical outcome.Patients and MethodsWe retrospectively reviewed 29 patients (17 women, 12 men) from our total joint registry who had undergone 31 cemented TKAs after a DFO between 2000 and 2012. Their mean age at TKA was 51 years (22 to 76) and their mean body mass index 32 kg/m2(20 to 45). The mean time between DFO and TKA was ten years (2 to 20). The mean follow-up from TKA was ten years (2 to 16). The prostheses were posterior-stabilized in 77%, varus-valgus constraint (VVC) in 13%, and cruciate-retaining in 10%. While no patient had metaphyseal fixation (e.g. cones or sleeves), 16% needed a femoral stem.ResultsThe ten-year survivorship was 95% with aseptic loosening as the endpoint, 88% with revision for any reason as the endpoint, and 81% with re-operation for any reason as the endpoint. Three TKAs were revised for instability (n = 2) and aseptic tibial loosening (n = 1). No femoral component was revised for aseptic loosening. Patients under the age of 50 years were at greater risk of revision for any reason (hazard ratio 7; p = 0.03). There were two additional re-operations (6%) and four complications (13%), including three manipulations under anaesthetic (MUA; 10%). The Knee Society scores improved from a mean of 50 preoperatively (32 to 68) to a mean of 93 postoperatively (76 to 100; p < 0.001).ConclusionA cemented posterior-stabilized TKA has an 88% ten-year survivorship with revision for any reason as the endpoint. No femoral component was revised for aseptic loosening. Patients under the age of 50 years have a greater risk of revision. The clinical outcome was significantly improved but balancing the knee was challenging in 13% of TKAs requiring VVC. Overall, 10% of TKAs needed an MUA, and 6% of TKAs were revised for instability. Cite this article: Bone Joint J 2019;101-B:660–666.
Deregulation of Long Intergenic Non-coding RNAs in CD4+ T Cells of Lamina Propria in Crohn’s Disease Through Transcriptome Profiling
Neto, Manuel B. Braga , Gaballa, Joseph M. , Bamidele, Adebowale O. , Sarmento, Olga F., Svingen, Phyllis A., Gonzalez, Michelle , Ramos, Guilherme Piovezani , Sagstetter, Mary R., Aseem, Sayed Obaidullah , Faubion, William A. , Braga-Neto, Manuel B, Svingen, Phyllis, Bamidele, Adebowale O , Braga Neto, Manuel B , Ramos, Guilherme P , Sun, Zhifu

Mayo Clinic

Journal of Crohn's and Colitis | May 31, 2019 | Volume: 14 | Issue: 1 | Pages: 96-109

10.1093/ecco-jcc/jjz109 | PMID 31158273 Get It

Abstract Background The aetiology of Crohn’s disease [CD] involves immune dysregulation in a genetically susceptible individual. Genome-wide association studies [GWAS] have identified 200 loci associated with CD, ulcerative colitis, or both, most of which fall within non-coding DNA regions. Long non-coding RNAs [lncRNAs] regulate gene expression by diverse mechanisms and have been associated with disease activity in inflammatory bowel disease. However, disease-associated lncRNAs have not been characterised in pathogenic immune cell populations. Methods Terminal ileal samples were obtained from 22 CD patients and 13 controls. RNA from lamina propria CD4+ T cells was sequenced and long intergenic non-coding RNAs [lincRNAs] were detected. Overall expression patterns, differential expression [DE], and pathway and gene enrichment analyses were performed. Knockdown of novel lincRNAs XLOC_000261 and XLOC_000014 was performed. Expression of Th1 or Th17-associated transcription factors, T-bet and RORγt, respectively, was assessed by flow cytometry. Results A total of 6402 lincRNAs were expressed, 960 of which were novel. Unsupervised clustering and principal component analysis showed that the lincRNA expression discriminated patients from controls. A total of 1792 lincRNAs were DE, and 295 [79 novel; 216 known] mapped to 267 of 5727 DE protein-coding genes. The novel lincRNAs were enriched in inflammatory and Notch signalling pathways [p &lt;0.05]. Furthermore, DE lincRNAs in CD patients were more frequently found in DNA regions with known inflammatory bowel disease [IBD]-associated loci. The novel lincRNA XLOC_000261 negatively regulated RORγt expression in Th17 cells. Conclusions We describe a novel set of DE lincRNAs in CD-associated CD4+ cells and demonstrate that novel lincRNA XLOC_000261 appears to negatively regulate RORγt protein expression in Th17 cells.
New Prospects for Medical Management of Acute Alcoholic Hepatitis
Liu, Mengfei , Shah, Vijay H.

Mayo Clinic

Clinical Liver Disease | May 31, 2019 | Volume: 13 | Issue: 5 | Pages: 131-135

10.1002/cld.792 | PMID 31236260 Get It

NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis
Yang, Sushan , Huang, Shi , Daniels, Lori B. , Cannone, Valentina , Burnett, John C. , Beckman, Joshua A. , Carr, J. Jeffrey , Wang, Thomas J. , Gupta, Deepak K. , Gupta, Deepak K , Daniels, Lori B , Yeboah, Joseph , Lima, João A.C. , Beckman, Joshua A

Mayo Clinic

Heart | May 31, 2019 | Volume: 105 | Issue: 20 | Pages: 1590-1596

10.1136/heartjnl-2019-314707 | PMID 31152069 Get It

Objective Natriuretic peptides (NPs) are hormones with cardioprotective effects. NP levels vary by race; however, the pathophysiological consequences of lower NP levels are not well understood. We aimed to quantify the association between NPs and endothelial function as measured by flow-mediated dilation (FMD) and the contribution of NP levels to racial differences in endothelial function. Methods In this cross-sectional study of 2938 Multi-Ethnic Study of Atherosclerosis participants (34% Caucasian, 20% African-American, 20% Asian-American and 26% Hispanic) without cardiovascular disease at baseline, multivariable linear regression models were used to examine the association between serum N-terminal pro-B-type NP (NT-proBNP) and natural log-transformed FMD. We also tested whether NT-proBNP mediated the relationship between race and FMD using the product of coefficients method. Results Among African-American and Chinese-American individuals, lower NT-proBNP levels were associated with lower FMD, β=0.06 (95% CI: 0.03 to 0.09; p<0.001) and β=0.06 (95% CI: 0.02 to 0.09; p=0.002), respectively. Non-significant associations between NT-proBNP and FMD were found in Hispanic and Caucasian individuals. In multivariable models, endothelial function differed by race, with African-American individuals having the lowest FMD compared with Caucasians, p<0.001. Racial differences in FMD among African-Americans and Chinese-Americans were mediated in part by NT-proBNP levels (African-Americans, mediation effect: −0.03(95% CI: −0.05 to −0.01); Chinese-Americans, mediation effect: −0.03(95% CI: −0.05 to −0.01)). Conclusions Lower NP levels are associated with worse endothelial function among African-Americans and Chinese-Americans. A relative NP deficiency in some racial/ethnic groups may contribute to differences in vascular function.